Study groups

Referral group
Between October 1993 and December 1995, 254 women with a pathological cervical smear, referred for colposcopy in Västerbotten county were asked to participate. One hundred and seventy-four women were referred from the population-based cervical screening programme and 76 because of smears taken outside the programme. They were referred to any of the three hospitals in Västerbotten county: Umeå University Hospital, Skellefteå Community Hospital or Lycksele Community Hospital. Four of the referred women refused to participate in the study, and the remaining 250 were enrolled. One hundred and thirty-seven of these women were finally diagnosed with CIN 2-3. The final diagnosis was based on blinded histopathological re-classification by an experienced pathologist of stored archival biopsy specimens (130 cases) and for seven cases where an archival biopsy was not available, on a blinded reclassification of the cytological archival specimen. The mean age was 37.2 years (range 21-58).
Screening group
A group of women who were invited by letter for screening in the organized programme were asked by an additional enclosed letter to attend the study. The women were selected randomly from the population registry and matched to the referrals 1:1 for age (±3 years) and area of residence. From October 1995 until March 1996, out of 2191 invited women, 871 were asked to participate and 320 accepted. In order to find out the reason 63% did not accept the invitation, a randomly selected subgroup of 50 of these women was interviewed by telephone by the same investigator. Two were not interested to participate in the screening programme at all. The other 48 women had recently seen or intended to see a doctor or midwife for screening and did not want to participate because of inconvenience.
Sampling procedures
In January 1995, the organized screening programme switched cervical sampling device to Cervex brush (Cortec Medical AB, Malmö, Sweden) that permits collecting cell samples from both ecto-and endocervix. The 114 samples that were taken before that time were taken with a cotton-tipped pin in the endocervix and a wooden spatula from the ectocervix and posterior fornix. Before colposcopic examination, a sample for HPV DNA was taken from the endocervix by a rotary motion with a Cytobrush (Medscand, Malmö, Sweden) for detection of cervical HPV DNA by nested polymerase chain reaction (PCR) with consensus primers and type-specific primers for HPV 11, 16, 18 and 33. The HPV sample was stored in physiologic saline containing 10 mM Tris-HCl buffer, pH 7.8 and kept at -70°C until analysis. If the colposcopic examination was normal an annual follow-up was arranged.
In the screening population, all women were examined by the same physician. Samples for cytomorphology and HPV DNA detection was taken and stored in the same manner as for referrals after January 1995. Although the sample for HPV DNA detection was taken identically for all cases and controls, the fact that the 114 cases sampled in 1993-1994 had had their previous Pap smear taken with a different utensil might have introduced differential misclassification bias. This was investigated by comparing the HPV results for cases sampled before and after January 1995, and no differences were found (Kjellberg et al, 1998) .
Questionnaire
The women answered a questionnaire concerning dietary habits, tobacco use, health conditions, psychosocial situation and an 11-item questionnaire about sexual and reproductive history.
The food frequency part included 84 items with an increasing nine-level scale, ranging from never eaten to eaten four or more times per day and the respondents were asked to report their usual intake of food during the last year. A standardized portion size adjusted for sex and age was used.
The energy and nutrients contents were calculated using the database from the National Food Administration (Bergström et al, 1991) . The reported frequencies of consumption were converted into number of intakes per day and the total intake of energy and nutrients was estimated.
Missing answers in the food groups with several alternative items and where one of the alternatives was eaten frequently, such as milk products and types of fats for bread, were interpreted as being never eaten.
The food frequency questionnaire has been extensively validated previously (Johansson et al, 1994; submitted) .
Analysis
HPV PCR analysis, HPV typing and antibody analysis were carried out as described previously (Kjellberg et al, 1998) .
Statistical analysis
Using the Statistical Package for the Social Sciences (SPSS) program software, conditional logistic regression analysis was used to calculate the odds ratios (OR) with 95% confidence interval (CI).
RESULTS
A total of 543 women answered the food questionnaire and 448 were eligible as cases (histological diagnosis of CIN 2-3) or controls (normal cytology). Nineteen women had too many missed answers (> 6 items) and five reported an unrealistic energy intake (<500 kcal or > 3500 kcal) and were therefore excluded. Five hundred and forty women had answered the questionnaire about smoking habits and 468 were eligible as cases or controls. The questionnaire about sexual history was answered by 556 women of which 480 were eligible. The distribution of dietary intake among women with normal cervical cytology and with CIN 2-3 is presented in Table 1 . Drinking boiled coffee and a high intake of dairy products were the only significant positive associations. The point estimates changed only marginally after taking HPV and smoking into account (data not shown). A reduced risk associated with tea drinking and increased intake of vegetable fibres was not significant after adjusting for HPV DNA and smoking (Table 1) .
A prolonged period of oral contraceptive (OC) use (more than 5 years) was associated with an increased risk for CIN 2-3 (P < 0.05), but this risk disappeared after adjustment for HPV, smoking and age (Table 2 ). Since OC use has been postulated to act via influencing the folate status (Butterworth et al, 1982; Harper et al, 1994 ) the possibility of an interaction between OC use and folate status was investigated. There was no OC-associated risk for CIN 2-3, neither among women with high, nor among women with low, folate intake (data not shown). A significant risk for CIN 2-3 was found for an early age at first coitus and for the number of lifetime sexual partners, but after adjusting for HPV, smoking and age this association disappeared (Table 2) . Pregnancy was not a risk factor in the crude analysis, but having been pregnant was revealed as a strong risk factor in the adjusted analysis (Table 2) .
Smoking history was associated with a risk for CIN 2-3 and adjusting for HPV did not affect the point estimate. Stratified analysis of the effect of covarying risk factors among HPV-positive women only has been proposed by Schiffman et al, (1993) as a preferred analysis method instead of adjusting for HPV. Such analysis was, however, not meaningful because of too few women The data on number of lifetime sexual partners has also been published in Kjellberg et al (1999) . in the reference category. There was a dose-effect relationship with the number of cigarettes smoked per day (Table 3) . Possible interaction between HPV16 and smoking was explored using the jointly negative as the reference category (Olsen et al, 1998) .
Smoking increased the point estimate of the CIN 2-3 risk both among HPV DNA positive and negative women and both among HPV seropositive and seronegative women, but there was no evidence of interaction (Table 4) .
DISCUSSION
This is one of only few population-based studies of the CIN 2-3 risk associated with major environmental risk factors such as smoking, diet and oral contraceptives that has taken HPV exposure into account. Earlier studies have commonly been contradictory. Micronutrients such as folic acid, vitamins A, E, C and β-carotene have in some studies shown a protective effect on cervical cancer and CIN (Cuzick et al, 1990; Slattery et al, 1990; Herrero et al, 1991; Liu et al, 1993) and some other studies not (Ziegler et al, 1991; Palan et al, 1998; Wideroff et al, 1998) . In our study, we could not show any protective effect of these dietary components and risk for CIN 2-3, not even before adjustment for HPV. We measured food intake and not serum levels of micronutrients, but neither this study nor some of the studies that also analysed serum levels of micro-nutrients could show any association to CIN 2-3 (Butterworth et al, 1992; Ho et al, 1998) . Oral contraceptive pill intake has been postulated to induce a local folic acid deficiency and interfere with DNA synthesis, repair or somehow alter the susceptibility of cells to oncogenic viruses or chemical carcinogens and therefore be a risk factor for CIN (Butterworth et al, 1982; Harper et al, 1994) . We found no association of folate intake with CIN 2-3 in the first place and also did not detect any interaction between folate intake and OC use. The risk associated with prolonged OC use was entirely explained by taking HPV into account.
The dietary associations found in this study (increased risk associated with boiled coffee and with high intake of dairy products) have not been consistently found in previous studies and the possibility exists that they may be chance associations attributable to multiple hypothesis testing. Further studies would be needed to evaluate the consistency of these risks. As earlier shown, retrospective collection of dietary information can lead to misclassification and to biased estimates as compared to prospectively collected dietary information, i.e. 'recall bias' (Michaelsson et al, 1996) .
In the present study, cofactors were studied taking both HPV DNA presence (present/persistent infection) and HPV seropositivity (cumulative exposure) into account. This is intended to allow distinguishing between cofactors independent of HPV (not affected by HPV adjustments), cofactors confounded by risk of HPV exposure (eliminated both by adjusting for HPV seropositivity and for HPV DNA) and cofactors that determine whether HPV is cleared or becomes persistent (eliminated by adjusting for HPV DNA, not affected by adjusting for HPV seropositivity). However, HPV seropositivity is not completely sensitive (estimated at 50-70% sensitivity; Kjellberg et al, 1999 ) and attenuation but not elimination of risks after adjusting for HPV seropositivity may also reflect residual confounding.
Sexual history is an established risk factor for CIN and cervical cancer. In a previous paper, we have found that HPV-infection explained this association and that sexual history per se thus was not a risk factor (Kjellberg et al, 1999) . In this study we detected the well known association between early age of sexual debut and risk for CIN, but again this association lost significance after adjusting for HPV infection.
Parity has repeatedly been found to be a cervical cancer risk factor (Schiffmann and Brinton, 1995) also after taking HPV DNA into account (Schiffmann et al, 1993) . Causal models that have been proposed are trauma to the cervix or hormonal effects Adjusted odds ratios for HPV seropositivity and age. (Schiffman and Brinton, 1995) . Since very few women in our study were multiparous, we investigated a possible effect of pregnancy. There was no association in the crude analyses, but a strong association was revealed after taking HPV into account. Our study thus suggests that pregnancy may both increase the risk for CIN 2-3 and protect against HPV infection. Previous literature on the interaction between HPV infection and pregnancy has not been consistent and further studies on the subject would seem to be warranted. The effects of smoking have been well studied and show a strong association to CIN and cervical cancer (Cuzick et al, 1990; Winkelstein, 1990; Phillips and Smith, 1994; Ho et al, 1998; Kruger-Kjaer et al, 1998; Olsen et al, 1998) . Chemical carcinogens in tobacco, such as cotinine and nicotine, probably exert a mitogenic effect by activating carcinogenic nitrosamines and causing DNA damage and also may impair the local immune defence in the cervical epithelium. However, the fact that smoking as a behaviour in some populations is associated with a lifestyle with increased risk for HPV infection has suggested that the association seen with smoking may be due to residual confounding from HPV or other sexually transmitted pathogens (Winkelstein, 1990; Ho et al, 1998) . The fact that the significant excess risk for CIN 2-3 associated with smoking was not reduced by adjustment for HPV indicates that smoking does indeed have a causal association with CIN 2-3. This is also supported by reports indicating that smoking cessation facilitates regression of CIN (Szarewski et al, 1996) . Whether smoking is an entirely independent risk factor or works as a risk modifier of HPV exposure could not be disclosed in the present study.
In summary, we found little evidence that variations within the normal Swedish food intake influences the risk for cervical neoplasia, nor that oral contraceptive use per se influences this risk. By contrast, the association with smoking was dose-dependent and could not be explained by confounding by HPV. The present study supports the concept that the risk associated with smoking is causal.
